Similar to patients with AAE-C1-INH, a lack of clinical trials and approved treatment options forces physicians to treat patients with HAE-nC1-INH according to their experience with patients with C1-INH-HAE. This evidence concerns the gene SERPING1 and hereditary angioedema.